Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 388

1.

Management of arterial hypertension in obese patients.

Wenzel UO, Krebs C.

Curr Hypertens Rep. 2007 Dec;9(6):491-7. Review.

PMID:
18367013
2.

Treatment of arterial hypertension in obese patients.

Wenzel UO, Krebs C.

Contrib Nephrol. 2006;151:230-42. Review.

PMID:
16929146
3.

Treatment of arterial hypertension in obese patients.

Wenzel UO, Benndorf R, Lange S.

Semin Nephrol. 2013 Jan;33(1):66-74. doi: 10.1016/j.semnephrol.2012.12.009. Review.

PMID:
23374895
4.

Clinical evidence for drug treatments in obesity-associated hypertensive patients--a discussion paper.

Doggrell SA.

Methods Find Exp Clin Pharmacol. 2005 Mar;27(2):119-25. Review.

PMID:
15834464
5.

Optimizing blood pressure control in the obese patient.

Pischon T, Sharma AM.

Curr Hypertens Rep. 2002 Oct;4(5):358-62. Review.

PMID:
12217253
6.

[Therapeutic options for metabolic syndrome in obese patients].

Carella AM, Conte M.

Clin Ter. 2007 Sep-Oct;158(5):457-64. Review. Italian.

PMID:
18062354
7.

Obesity-related hypertension: its physiological basis and pharmacological approaches to its treatment.

Richards RJ, Thakur V, Reisin E.

J Hum Hypertens. 1996 Sep;10 Suppl 3:S59-64. Review.

PMID:
8872829
8.

Metabolic considerations in hypertension.

Tuck ML.

Am J Hypertens. 1990 Dec;3(12 Pt 2):355S-365S. Review.

PMID:
2078323
9.

Obesity in hypertension: effects on prognosis and treatment.

Kaplan NM.

J Hypertens Suppl. 1998 Jan;16(1):S35-7. Review.

PMID:
9534095
10.

Choice of drug treatment for obesity-related hypertension: where is the evidence?

Sharma AM, Pischon T, Engeli S, Scholze J.

J Hypertens. 2001 Apr;19(4):667-74. Review.

PMID:
11330867
11.

[Antihypertensive drug utilization in obese patients].

Bramlage P, Bramlage C, Kirch W.

Med Klin (Munich). 2005 Dec 15;100(12):804-9. German.

PMID:
16453095
12.

Obesity, essential hypertension and renin-angiotensin system.

Segura J, Ruilope LM.

Public Health Nutr. 2007 Oct;10(10A):1151-5. Review.

PMID:
17903324
13.

Managing hypertension using combination therapy.

Frank J.

Am Fam Physician. 2008 May 1;77(9):1279-86. Review.

14.

Antihypertensive therapy in the obese hypertensive patient.

Chrostowska M, Szczech R, Narkiewicz K.

Curr Opin Nephrol Hypertens. 2006 Sep;15(5):487-92. Review.

PMID:
16914960
15.

Endocrine arterial hypertension: therapeutic approach in clinical practice.

Mazza A, Armigliato M, Zamboni S, Rempelou P, Rubello D, Pessina AC, Casiglia E.

Minerva Endocrinol. 2008 Dec;33(4):297-312. Review.

PMID:
18923367
16.

[Metabolic syndrome in patients with hypertension].

Aganović I, Dusek T.

Lijec Vjesn. 2006 Nov-Dec;128(11-12):333-6. Croatian.

PMID:
17212193
17.

[Lowering blood pressure in obese hypertensive patients. Which antihypertensive drugs are suitable].

Pischon T, Sharma AM.

MMW Fortschr Med. 2001 Nov 29;143(48):34-8. German.

PMID:
11770373
18.

[Hypertension combination therapy with renin-angiotensin system blockers].

Soucek M.

Vnitr Lek. 2009 Sep;55(9):719-23. Review. Czech.

PMID:
19785368
19.

Resistant hypertension: an overview of evaluation and treatment.

Sarafidis PA, Bakris GL.

J Am Coll Cardiol. 2008 Nov 25;52(22):1749-57. doi: 10.1016/j.jacc.2008.08.036. Review.

20.

Secondary hypertension: obesity and the metabolic syndrome.

Singer GM, Setaro JF.

J Clin Hypertens (Greenwich). 2008 Jul;10(7):567-74. Review.

Supplemental Content

Support Center